Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  2004-07-29

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-004-1953-0PMID 15290005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabis use and age at onset of schizophrenia.

  2004cited by this paper
• Causal association between cannabis and psychosis: examination of the evidence

  2004cited by this paper
• Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication

  2004cited by this paper
• Genetic Vasopressin Deficiency Facilitates Performance of a Lateralized Reaction-Time Task: Altered Attention and Motor Processes

  2003cited by this paper
• Effects of Δ9-THC and WIN-55,212-2 on place preference in the water maze in rats

  2003cited by this paper
• Attentional effects of nicotine and amphetamine in rats at different levels of motivation

  2003cited by this paper
• Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus: Site and Mechanism of Action

  2003cited by this paper
• Neural mechanisms of general fluid intelligence

  2003cited by this paper
• Sex-related differences in spatial divided attention and motor impulsivity in rats.

  2003cited by this paper
• Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat

  2003cited by this paper
• Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

  2002cited by this paper
• Endocannabinoids and cannabinoid receptor genetics.

  2002cited by this paper
• The frontal cortex of the rat and visual attentional performance: dissociable functions of distinct medial prefrontal subregions.

  2002cited by this paper
• Endocannabinoids in cognition and dependence.

  2002cited by this paper
• Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats

  2002cited by this paper
• Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

  2002cited by this paper
• Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes

  2002cited by this paper
• The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats

  2002cited by this paper
• Cognitive functioning of long-term heavy cannabis users seeking treatment.

  2002cited by this paper
• Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study

  2002cited by this paper
• Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.

  2002cited by this paper
• The endogenous cannabinoid system controls extinction of aversive memories

  2002cited by this paper
• Cannabis use correlates with schizotypal personality traits in healthy students.

  2002cited by this paper
• Rodent models of prefrontal cortical function.

  2002cited by this paper
• Evaluation of CB1 receptor knockout mice in the Morris water maze.

  2002influential reference
• The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

  2002cited by this paper
• Relationship between Cannabis Use, Schizotypal Traits, and Cognitive Function in Healthy Subjects

  2001cited by this paper
• Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study.

  2001cited by this paper
• Effects of intralaminar thalamic lesions on sensory attention and motor intention in the rat: a comparison with lesions involving frontal cortex and hippocampus.

  2001influential reference
• Differential effects of delta 9-THC on spatial reference and working memory in mice.

  2001cited by this paper
• Functional disconnection of a prefrontal cortical-dorsal striatal system disrupts choice reaction time performance: implications for attentional function.

  2001cited by this paper
• Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance.

  2001cited by this paper
• Differential effects of Δ9-THC on spatial reference and working memory in mice

  2001cited by this paper
• Psychiatric effects of cannabis

  2001influential reference
• The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

  2001cited by this paper
• Δ9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

  2001cited by this paper
• Cannabinoids Reveal the Necessity of Hippocampal Neural Encoding for Short-Term Memory in Rats

  2000cited by this paper
• The Effects of a Sub-Anaesthetic Dose of Ketamine on Human Selective Attention

  2000cited by this paper
• A performance-dependent adjustment of the retention interval in a delayed non-matching-to-position paradigm differentiates effects of amnestic drugs in rats.

  2000influential reference
• SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats.

  2000cited by this paper
• Effects of synthetic Δ9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man

  1999cited by this paper
• Behavioral effects of cannabinoid agents in animals.

  1999cited by this paper
• The effects of cannabinoids on the brain.

  1999cited by this paper
• Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat.

  1999cited by this paper
• Elevated endogenous cannabinoids in schizophrenia.

  1999cited by this paper
• Behavioral Effects of Cannabinoid Agents in Animals.

  1999cited by this paper
• Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

  1998cited by this paper
• SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity.

  1998cited by this paper
• Lack of psychotomimetic or impairing effects on psychomotor performance of acamprosate.

  1998cited by this paper
• Cannabinoid/anandamide system and schizophrenia: is there evidence for association?

  1998cited by this paper
• Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

  1998cited by this paper
• The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by Δ9-tetrahydrocannabinol or anandamide

  1998cited by this paper
• The Neural Correlates of the Noradrenergic Modulation of Human Attention, Arousal and Learning

  1997cited by this paper
• SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats.

  1997cited by this paper
• Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966.

  1997cited by this paper
• The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task.

  1996cited by this paper
• Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

  1996cited by this paper
• Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A.

  1996cited by this paper
• Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats

  1995influential reference
• Localization of cannabinoid receptor mRNA in rat brain

  1993cited by this paper
• Neurobiology of marijuana abuse.

  1992cited by this paper
• Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

  1991cited by this paper
• Glucose Metabolic Rate in Normals and Schizophrenics During the Continuous Performance Test Assessed by Positron Emission Tomography

  1990cited by this paper
• Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention

  1985cited by this paper
• Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal.

  1983cited by this paper
• Divided attention performance of cannabis users and non-users following cannabis and alcohol

  1975cited by this paper
• Rodent models of prefrontal cortical function

  year unknowncited by this paper

• The Effects of THC and Nicotine on Attention: A Narrative Review.

  2025cites this paper
• Sub‐chronic administration of AM6545 enhances cognitive performance and induces hippocampal synaptic plasticity changes in naïve mice

  2025cites this paper
• Sub-chronic peripheral CB1R inhibition enhances cognitive performance and induces hippocampal synaptic plasticity changes in naïve mice

  2024cites this paper
• spatial learning performance and altered

  2023cites this paper
• Allele-dosage genetic polymorphisms of cannabinoid receptor 1 predict attention, but not working memory performance in humans.

  2021cites this paper
• Effects of Mephedrone and Amphetamine Exposure during Adolescence on Spatial Memory in Adulthood: Behavioral and Neurochemical Analysis

  2021cites this paper
• Lateral habenula cannabinoid CB1 receptor involvement in drug-associated impulsive behavior.

  2021cites this paper
• Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention

  2021cites this paper
• Synthetic cannabinoids in Europe – a review

  2021cites this paper
• Enhancing effects of acute exposure to cannabis smoke on working memory performance

  2019cites this paper
• Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease

  2019cites this paper
• Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder.

  2018cites this paper
• Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon

  2018cites this paper
• Examination of the effects of cannabinoid ligands on decision making in a rat gambling task

  2018cites this paper
• The long-term cognitive consequences of adolescent exposure to recreational drugs of abuse

  2018cites this paper
• The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review

  2018influential citation
• The effects of synthetic cannabinoids on executive function

  2017cites this paper
• A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.

  2017cites this paper
• Impaired cued and spatial learning performance and altered cannabinoid CB₁ receptor functionality in the substantia nigra in a rat model of diabetic neuropathy.

  2016cites this paper
• Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling

  2016cites this paper
• Cannabis, Endocannabinoid CB1 Receptors, and the Neuropathology of Vision

  2016cites this paper
• Acute Pancreatitis Secondary to Marijuana Consumption

  2016cites this paper
• Dissociable Deficits of Executive Function Caused by Gestational Adversity are Linked to Specific Transcriptional Changes in the Prefrontal Cortex

  2015cites this paper
• Endocannabinoids and striatal function: implications for addiction-related behaviours

  2015cites this paper
• Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats

  2015influential citation
• Cannabinoid receptor function in the medial prefrontal cortex

  2013cites this paper
• Sensory gating, cannabinoids and schizophrenia.

  2013cites this paper
• Anatomical, Biochemical, and Behavioral Evidence for Cannabinoid Modulation of Noradrenergic Circuits: Role of Norepinephrine in Cannabinoid-Induced Aversion

  2013cites this paper
• Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.

  2012cites this paper
• A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia

  2012cites this paper
• Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.

  2012cites this paper
• Estudio psicofarmacológico de la modulación del sistema cannabinoide y su implicación neurocomportamental en la adicción a cocaína

  2011cites this paper
• The role of the endocannabinoid system in attention and nicotine addiction

  2011cites this paper
• Cannabinoid CB1 Receptor Activation Mediates the Opposing Effects of Amphetamine on Impulsive Action and Impulsive Choice

  2011cites this paper
• SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.

  2010cites this paper
• Modulation of limbic noradrenergic circuits by cannabinoids

  2010cites this paper
• How the Brain Makes Play Fun.

  2010cites this paper
• Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis

  2010cites this paper
• Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

  2009cites this paper
• Terpenóides com atividade sobre o Sistema Nervoso Central (SNC)

  2009cites this paper
• Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats

  2009influential citation
• Sensory gating in the hippocampus and the medial prefrontal cortex

  2008cites this paper
• The neuropharmacology of impulsive behaviour.

  2008cites this paper
• Cannabinoid modulation of executive functions.

  2008influential citation
• Revisión sobre el consumo de cannabis como factor de riesgo de la esquizofrenia

  2007cites this paper
• Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats

  2007cites this paper
• Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

  2007cites this paper
• Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia

  2007cites this paper
• Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats.

  2007cites this paper
• Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons

  2006cites this paper
• Cannabinoids and prefrontal cortical function: insights from preclinical studies.

  2006influential citation
• Nicotine and cannabinoids: parallels, contrasts and interactions.

  2006cites this paper
• A role for cannabinoid CB1 receptors in mood and anxiety disorders

  2005cites this paper
• A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.

  2005cites this paper
• The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats

  2005cites this paper
• The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats

  2005cites this paper